Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36/LACK protective antigen from Leishmania infantum.

The p36/LACK antigen from Leishmania, an analogue of the receptor for activated protein kinase C (PKC), induces high levels of protection against parasite infection in the BALB/c mouse model. This protection is more than twice as high as that elicited by major parasite antigens such as soluble Leishmania antigen or the main surface protease gp63. We have cloned and purified p36/LACK from Leishmania infantum, the causative agent of visceral leishmaniasis in Europe. This protein belongs to the large family of WD 40 repeat proteins confined to eukaryotes and involved in numerous regulatory functions. Differential solubilization and immunofluorescence experiments indicate that p36/LACK is present close to the kinetoplast disc in the cell cytoplasm, probably bound to multiprotein complexes but not to membrane structures. These complexes probably also include cytoplasm PKC isoforms. The use of a genetically-encoded peptide library indicates that p36/LACK binds sequences present in several proteins involved in DNA replication and RNA synthesis. The recognition and binding sequences present in vacuolar proteins and at the beta-chain of major histocompatability complex (MHC) class II suggest the involvement of this regulatory protein in the early mechanisms triggering the protective immune response of the host against the parasite infection.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  Carl Wu,et al.  Drosophila NURF-55, a WD repeat protein involved in histone metabolism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Glaichenhaus,et al.  Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major , 1997, The Journal of experimental medicine.

[4]  P. T. Englund,et al.  A Mitochondrial DNA Primase from the Trypanosomatid Crithidia fasciculata * , 1997, The Journal of Biological Chemistry.

[5]  H. Moll,et al.  Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major , 1997, Infection and immunity.

[6]  F. Almazán,et al.  Cloning of the gp63 surface protease of Leishmania infantum. Differential post-translational modifications correlated with different infective forms. , 1997, Biochimica et biophysica acta.

[7]  J. Sun,et al.  Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. , 1997, Journal of immunology.

[8]  N. Glaichenhaus,et al.  Selective down‐regulation of Th2 immune responses following treatment with antigen‐coupled splenocytes , 1997, European journal of immunology.

[9]  N. Glaichenhaus,et al.  Resistance to Leishmania major Induced by Tolerance to a Single Antigen , 1996, Science.

[10]  D. Margulies,et al.  Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. , 1996, Journal of molecular biology.

[11]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[12]  F. Modabber.  Vaccines against leishmaniasis. , 1995, Annals of tropical medicine and parasitology.

[13]  S. Beverley,et al.  Development of a safe live Leishmania vaccine line by gene replacement. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Sette,et al.  Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Glimcher,et al.  Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. , 1995, The Journal of infectious diseases.

[16]  R. Locksley,et al.  Expression cloning of a protective Leishmania antigen. , 1995, Science.

[17]  G. Trinchieri,et al.  The role of interleukin 12 in the immune response, disease and therapy. , 1994, Immunology today.

[18]  Raman Nambudripad,et al.  The ancient regulatory-protein family of WD-repeat proteins , 1994, Nature.

[19]  J. Donelson,et al.  Sequence diversity and organization of the msp gene family encoding gp63 of Leishmania chagasi. , 1993, Molecular and biochemical parasitology.

[20]  R. Locksley,et al.  Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. , 1993, Science.

[21]  M. Röllinghoff,et al.  Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen‐specific T cells , 1993, European journal of immunology.

[22]  W. Paul,et al.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.

[23]  D. Ward,et al.  In situ hybridization to the crithidia fasciculata kinetoplast reveals two antipodal sites involved in kinetoplast DNA replication , 1992, Cell.

[24]  M. Wilson,et al.  Hydrogen peroxide-mediated toxicity for Leishmania donovani chagasi promastigotes. Role of hydroxyl radical and protection by heat shock. , 1991, The Journal of clinical investigation.

[25]  T. Gettys,et al.  Alterations in mRNA levels, expression, and function of GTP-binding regulatory proteins in adipocytes from obese mice (C57BL/6J-ob/ob). , 1991, The Journal of biological chemistry.

[26]  P. Parker,et al.  Protein kinase C heterogeneity in GH4C1 rat pituitary cells. Characterization of a Ca2(+)-independent phorbol ester receptor. , 1990, The Journal of biological chemistry.

[27]  R. Barrett,et al.  Peptides on phage: a vast library of peptides for identifying ligands. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Simpson,et al.  A protein kinase C isozyme is translocated to cytoskeletal elements on activation. , 1990, Cell regulation.

[29]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[30]  E. Handman,et al.  Leishmania major: production of recombinant gp63, its antigenicity and immunogenicity in mice. , 1990, Experimental parasitology.

[31]  G. P. Smith,et al.  Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. , 1988, Gene.

[32]  D. Sacks,et al.  Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation , 1987, Infection and immunity.

[33]  A. Sher,et al.  Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. , 1987, Journal of Immunology.

[34]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[35]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[36]  R. Locksley,et al.  The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.

[37]  R. Titus,et al.  Role of T cells in immunity to the intracellular pathogen, Leishmania major. , 1992, Sub-cellular biochemistry.

[38]  O. Meyerhof.  THE ORIGIN OF THE REACTION OF HARDEN AND YOUNG IN CELL-FREE ALCOHOLIC FERMENTATION , 1945 .